FDA authorizes 1st over-the-counter, at-home COVID-19 test for emergency use
The Food and Drug Administration on Tuesday issued an emergency use authorization for the first over-the-counter, fully at-home COVID-19 test for emergency use. Previously, the agency authorized the first prescription COVID-19 test for home use, and the first non-prescription test system that allows people to take their own samples before sending it to a lab for analysis. The latest news appears to combine the best of the worlds.
The Ellume COVID-19 Home Test will likely be sold at pharmacies, and it won't require a prescription. FDA Commissioner Stephen Hahn said patients can buy the rapid antigen kit, take it home, conduct their own nasal swab, and get their results "in as little as 20 minutes." As is the case with most tests, the FDA cautions there is a risk of false positive and negative results.
Ellume says its intention is for the test to cost $30 or less and while production has just started, the company expects to send out initial shipments the first week of January.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There is hope that at-home testing will not only expand Americans' access to coronavirus testing, but also reduce the burden on laboratories and test supplies, Hahn said. Read more the FDA's full announcement here.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Quiz of The Week: 25 - 31 January
Have you been paying attention to The Week's news?
By The Week Staff Published
-
The Week Unwrapped: Are our phones fuelling a Congolese militia?
Podcast Plus, what's behind a spate of hate crimes in Australia? And why is carbon monoxide the new 'drug' of choice for cyclists?
By The Week UK Published
-
Peter Florence shares books that spark debate
The Week Recommends Co-founder of Hay Festival chooses works by Robert Macfarlane, Marion Turner and others
By The Week UK Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published